ISOENZYME-SPECIFIC QUANTITATIVE IMMUNOASSAYS FOR CYTOSOLIC GLUTATHIONE TRANSFERASES AND MEASUREMENT OF THE ENZYMES IN BLOOD-PLASMA FROM CANCER-PATIENTS AND IN TUMOR-CELL LINES

被引:40
作者
HAO, XY
CASTRO, VM
BERGH, J
SUNDSTROM, B
MANNERVIK, B
机构
[1] UNIV UPPSALA, CTR BIOMED, DEPT BIOCHEM, S-75123 UPPSALA, SWEDEN
[2] UNIV UPPSALA, AKAD SJUKHUSET, DEPT ONCOL, UPPSALA, SWEDEN
[3] SANGTEC MED AB, STOCKHOLM, SWEDEN
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1994年 / 1225卷 / 02期
关键词
GLUTATHIONE TRANSFERASE; TUMOR CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; BLOOD PLASMA;
D O I
10.1016/0925-4439(94)90082-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enzyme-linked immunoassays (ELISAs) based on the double-antibody sandwich technique have been developed for the quantitative analysis of the major human cytosolic class Pi, Mu and Alpha glutathione transferases (GSTs). The procedures were optimized with respect to antibody concentration for coating of plates as well as other parameters in order to achieve high sensitivity and accuracy. No cross-reactivity was detected between members of the three different classes of GSTs or among the Mu class GSTs M2-2, M3-3 and M4-4 with the ELISA for GST M1-1. The ELISAs have been applied to establish the cytosolic GST profiles of 10 cell lines and to monitor the plasma GST levels in cancer patients. The results revealed that the class Pi GST was the dominant isoenzyme in six (LS 174T, HCT-8, Hu 549 Pat, K-562, U-937 and Hu 549) out of nine tumor cell lines and immortalized hepatocytes (Chang Liver). The isoenzymes A1-1 and M1-1 were determined to be the major GST components in Hep G2 and HeLa cells, respectively. In a clinical study, the majority of the patients with urinary bladder cancer were found to have increased plasma levels of both GST A1-1 and GST P1-1 (10/15), while patients with renal cancer frequently showed increases only in GST P1-1 (5/8). The results demonstrate that the ELISAs are suitable for analyzing GST phenotypes in both normal and tumor cells and in monitoring plasma levels of GSTs in cancer patients.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 35 条
[1]   ANIONIC GLUTATHIONE S-TRANSFERASES OF HUMAN-ERYTHROCYTES, PLACENTA, AND LUNG - EVIDENCE FOR STRUCTURAL DIFFERENCES [J].
AHMAD, H ;
MEDH, RD ;
VONSINGH, S ;
CACCURI, AM ;
ANSARI, GAS ;
AWASTHI, YC .
ENZYME, 1989, 42 (03) :129-135
[2]   HUMAN-MUSCLE GLUTATHIONE S-TRANSFERASE (GST-4) SHOWS CLOSE HOMOLOGY TO HUMAN-LIVER GST-1 [J].
BOARD, PG ;
SUZUKI, T ;
SHAW, DC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 953 (03) :214-217
[3]   EXPRESSION OF HUMAN GLUTATHIONE S-TRANSFERASE-2 IN ESCHERICHIA-COLI - IMMUNOLOGICAL COMPARISON WITH THE BASIC GLUTATHIONE S-TRANSFERASES ISOENZYMES FROM HUMAN-LIVER [J].
BOARD, PG ;
PIERCE, K .
BIOCHEMICAL JOURNAL, 1987, 248 (03) :937-941
[4]  
BOSCATO LM, 1988, CLIN CHEM, V34, P27
[5]   DIFFERENCES AMONG HUMAN TUMOR-CELL LINES IN THE EXPRESSION OF GLUTATHIONE TRANSFERASES AND OTHER GLUTATHIONE-LINKED ENZYMES [J].
CASTRO, VM ;
SODERSTROM, M ;
CARLBERG, I ;
WIDERSTEN, M ;
PLATZ, A ;
MANNERVIK, B .
CARCINOGENESIS, 1990, 11 (09) :1569-1576
[6]  
COMSTOCK KE, 1993, J BIOL CHEM, V268, P16958
[7]   SIMILAR BIOCHEMICAL-CHANGES ASSOCIATED WITH MULTIDRUG RESISTANCE IN HUMAN-BREAST CANCER-CELLS AND CARCINOGEN-INDUCED RESISTANCE TO XENOBIOTICS IN RATS [J].
COWAN, KH ;
BATIST, G ;
TULPULE, A ;
SINHA, BK ;
MYERS, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (24) :9328-9332
[8]   THE HUMAN-LIVER GLUTATHIONE S-TRANSFERASE GENE SUPERFAMILY - EXPRESSION AND CHROMOSOME MAPPING OF AN HB SUBUNIT CDNA [J].
DEJONG, JL ;
CHANG, CM ;
WHANGPENG, J ;
KNUTSEN, T ;
TU, CPD .
NUCLEIC ACIDS RESEARCH, 1988, 16 (17) :8541-8554
[9]   A PILOT-STUDY OF PI-CLASS GLUTATHIONE-S-TRANSFERASE EXPRESSION IN BREAST-CANCER - CORRELATION WITH ESTROGEN-RECEPTOR EXPRESSION AND PROGNOSIS IN NODE-NEGATIVE BREAST-CANCER [J].
GILBERT, L ;
ELWOOD, LJ ;
MERINO, M ;
MASOOD, S ;
BARNES, R ;
STEINBERG, SM ;
LAZAROUS, DF ;
PIERCE, L ;
DANGELO, T ;
MOSCOW, JA ;
TOWNSEND, AJ ;
COWAN, KH .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) :49-58
[10]  
HAO XY, 1993, IN PRESS BIOCH J